LEXINGTON, Ky. (January 30, 2019) – The National Thoroughbred Racing Association (NTRA) Safety & Integrity Alliance and the Racing Medication Testing Consortium (RMTC) today announced that registration for the second Regulatory/Official Veterinarian Continuing Education Conference (RegVetCE19) is full.

The meeting scheduled for March 4-5 at Gulfstream Park Racing and Casino includes registrants from almost 50 North American racetracks in 20 U.S. jurisdictions, and six countries.

Organized by Steve Koch, executive director of the NTRA Safety & Integrity Alliance, and Dr. Dionne Benson, executive director and COO of the RMTC, participation in the conference is limited to active official veterinarians employed or sponsored by a racetrack or regulatory authority.

“The success of the inaugural RegVetCE, and the oversold registrations for its Gulfstream Park follow-up, signal that our regulatory veterinarians strongly value this critical initiative,” Koch said. “We are grateful to our financial supporters that make this program possible. Horses, horsemen and all racing stakeholders benefit from this collaboration that enables national uniformity of veterinary and regulatory procedures.”

The 2019 RegVetCE is officially approved for 18.25 veterinarian continuing education credits by the Registry of Approved Continuing Education (RACE) program of the American Association of Veterinary State Boards (AAVSB).

Speakers and topics for this year’s conference include:

·        Dr. Cynthia Cole D.V.M., Ph.D., D.A.C.V.C.P. (University of Florida) on pharmacology for regulatory veterinarians.

·        Dr. Barrie Grant D.V.M., M.S., D.A.C.V.S., M.R.C.V.S. (California Horse Racing Board) on pre-race examination decision-making.

·       Dr. Rick Arthur D.V.M. (California Horse Racing Board), Dr. Tessa Muir B.V.Sc., Cert. A.V.P., M.R.C.V.S. (British Horseracing Authority), and Izzy Trejo (New Mexico Racing Commission) on out of competition testing strategies

·        Dr. Mary Scollay D.V.M. (Kentucky Horse Racing Commission) on regulating therapeutic medication.

·        Anthony Fontana Ph.D (Truesdail Labs), Petra Hartmann M.S. (Industrial Labs), and Dr. Lynn Hovda RPh, D.V.M., M.S., D.A.C.V.I.M. (Minnesota Racing Commission) on laboratory performance standards.

·        Ashley Hill Ph.D (U.C. Davis) on statistics of medication regulation.

·       Dr. Kenton Morgan D.V.M., D.A.C.T. (Zoetis) on compounding, mislabeling, and illegal new medications.

·       Dr. Dionne Benson Esq. D.V.M. (Racing Medication & Testing Consortium), Dr. Tessa Muir (BHA) and Alex Waldrop Esq. (NTRA, RMTC) on comparing international and U.S. medication regulation.

“With an emphasis on medication, pharmacology, and medication regulation, RegVetCE19 enables participants to better communicate with all stakeholders regarding issues that affect horses, trainers, and veterinarians,” said Benson.

The inaugural two-day RegVetCE was held last June at Keeneland and covered topics related to pre-race examinations, on-track protocols, test barn best practices, data and documentation, technology resources, and biosecurity.

Regulatory/Official Veterinary CE is made possible with generous support from The Stronach Group, Keeneland, Racing Medication & Testing Consortium, NTRA Safety and Integrity Alliance, Hagyard Equine Medical Institute, New York Racing Association, ALS-Truesdail, Industrial Laboratories, American Association of Equine Practitioners, American Quarter Horse Association, Del Mar Thoroughbred Club, The Jockey Club, Kentucky Thoroughbred Association, Lone Star Park at Grand Prairie, New York Thoroughbred Horsemen’s Association, Oak Tree Racing Association, Ohio HBPA, Remington Park Racing and Casino, Texas A&M Veterinary Medical Diagnostic Laboratory, and University of Kentucky Ag Equine Programs.

About the RMTC

The RMTC consists of 23 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing. The organization works to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the racing public.

About the NTRA Safety & Integrity Alliance

The NTRA Safety & Integrity Alliance establishes and implements standards promoting safety and integrity in horseracing. Corporate partners of the Alliance include Insurance Office of America and Hagyard Equine Medical Institute. Information on the Alliance, including the Alliance Code of Standards, can be found at NTRAalliance.com.

About the NTRA

The NTRA, based in Lexington, Ky., is a broad-based coalition of more than 100 horse racing interests and thousands of individual stakeholders consisting of horseplayers, racetrack operators, owners, breeders, trainers and affiliated horse racing associations, charged with increasing the popularity, welfare and integrity of Thoroughbred racing through consensus-based leadership, legislative advocacy, safety and integrity initiatives, fan engagement and corporate partner development. The NTRA owns and manages the NTRA Safety and Integrity Alliance; NTRA.com; the Eclipse Awards; the National Horseplayers Championship; NTRA Advantage, a corporate partner sales and sponsorship program; and Horse PAC®, a federal political action committee. NTRA press releases appear on NTRA.com, Twitter (@ntra) and Facebook (facebook.com/1NTRA).